multiple
CAR T-Therapy for Multiple Myeloma Patients: Does Race or Ethnicity Impact Outcome?
CAR T-Therapy for Multiple Myeloma Patients: Does Race or Ethnicity Impact Outcome?
Source link
Multiple barriers impact BIPOC communities' mental health needs
According to the Substance Abuse and Mental Health Services Administration (SAMHSA), Black, Indigenous and People of Color (BIPOC) lack adequate in...
First case of recurrent multiple evanescent white dot syndrome (MEWDS) shown in woman following both COVID-19 vaccination and subsequent infection
A recent study from New Zealand found a woman diagnosed with multiple evanescent white dot syndrome (MEWDS) twice due to COVID-19 vaccination and s...
Trial for multiple sclerosis drug focused on Hispanic and Black patients
Illustration: Annelise Capossela/Axios
Researchers are conducting what they call a first of its kind clinical trial to study how Hispanic and Bla...
Disparities in Multiple Myeloma Treatment, Mortality Risk Observed Among Hispanic Americans
Hispanic Americans with multiple myeloma (MM) face disparities in treatment, clinical trial enrollment, and mortality risk, among other factors, wh...
National Mandatory Grain Fortification Legislation Decreases Anemia Prevalence among Nonpregnant Women of Reproductive Age: Findings from Multiple ...
Get help with access
Institutional access
Access to content on Oxford Academic is often provided through institutional subscripti...
Trending Topics
Features
- Drive Toolkit
Download and distribute powerful vaccination QI resources for your community.
- Health Champions
Sign up now to support health equity and sustainable health outcomes in your community.
- Cancer Early Detection
MCED tests use a simple blood draw to screen for many kinds of cancer at once.
- PR
FYHN is a bridge connecting health information providers to BIPOC communities in a trusted environment.
- Medicare
Discover an honest look at our Medicare system.
- Alliance for Representative Clinical Trials
ARC was launched to create a network of community clinicians to diversify and bring clinical trials to communities of color and other communities that have been underrepresented.
- Reducing Patient Risk
The single most important purpose of our healthcare system is to reduce patient risk for an acute event.
